Trimetazidine for diabetic nerve pain
Part of Brain & nervous system, Hormones & metabolism, Pain clinical trials.
This trial tests whether the drug trimetazidine can improve nerve damage symptoms in people with type 2 diabetes and diabetic neuropathy. It also looks at how the drug affects a substance in the blood called endothelin-1, which may be involved in nerve damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have type 2 diabetes.
- You have diabetic neuropathy.
- Your HbA1c (average blood sugar) is above 7%.
- You do not have any of the exclusion conditions listed (e.g., autoimmune disorders, serious organ disease, recent infection, pregnancy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether melatonin can help relieve pain and discomfort from diabetic peripheral neuropathy (nerve damage caused by diabetes). If you have type 2 diabetes with nerve pain and are on stable diabetes medications, you may be eligible.
This trial tests whether a weekly injection called tirzepatide can improve nerve pain and numbness related to diabetes. It may help people with type 2 diabetes who have nerve problems.
This study tests whether the medicine piracetam can help with nerve pain or symptoms caused by diabetes (diabetic neuropathy). If it works, it may offer a new way to ease discomfort and improve your daily life.
This trial tests an experimental medicine called suzetrigine to see if it can safely reduce pain caused by nerve damage from diabetes (diabetic peripheral neuropathy). It might be an option if you have had daily pain in both legs and current treatments haven't worked well enough.
This trial tests an experimental pain drug called suzetrigine for people with diabetic peripheral neuropathy (nerve damage from diabetes that causes pain in the feet and legs). It aims to see if the drug can safely reduce pain over time.
This study tests an investigational medicine (HL-1186) to see if it can reduce nerve pain caused by diabetes. If you have had burning or shooting pain in your feet or legs for at least 6 months, this trial might help find a new way to ease that pain.
Hear when a new Diabetic Peripheral Neuropathic Pain (DPN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.